Research progress on non-surgical treatment of ameloblastoma
10.3760/cma.j.cn113030-20200429-00225
- VernacularTitle:成釉细胞瘤的非手术治疗进展
- Author:
Yi JIN
1
;
Pei YANG
;
Hekun JIN
;
Xiangwei WU
;
Hui WANG
Author Information
1. 中南大学湘雅医学院附属肿瘤医院 湖南省肿瘤医院放疗中心，长沙 410013
- Keywords:
Ameloblastoma/radiotherapy;
Ameloblastoma/chemotherapy;
Ameloblastoma/molecule-targeted therapy;
Research progress
- From:
Chinese Journal of Radiation Oncology
2022;31(1):85-89
- CountryChina
- Language:Chinese
-
Abstract:
Ameloblastoma is a relatively common benign tumor that occurs in the dental epithelial tissues, which is characterized with local infiltration and growth, high-risk recurrence and metastasis, etc. At present, radical osteotomy is the main treatment of ameloblastoma, whereas it yields high recurrence rate and causes multiple postoperative complications such as facial and functional deformities, etc. For inoperable patients, non-surgical interventions, such as radiotherapy, chemotherapy and molecule-targeted therapy, are urgently needed to improve prognosis and retain organs. This article summarizes the current status and research progresses on non-surgical treatment of ameloblastoma, aiming to provide evidence for individualized treatment of ameloblastoma.
